Krishna Institute of Medical Sciences Limited · NSE:KIMS
Krishna Institute of Medical Sciences — Q2 FY27 Earnings Presentation
33 slides from Krishna Institute of Medical Sciences's earnings presentation, Nov 4, 2026
Slide 1: Exchange filing cover letter
04th November 2026 The General Manager, The Manager, Department of Corporate Services Listing Department Bombay Stock Exchange Ltd (BSE) National Stock Exchange of India Limited, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor, Dalal Street, Plot No.C/1, 'G' Block, Mumbai - 400 001. Bandra -
Slide 2: Investor Presentation
Investor Presentation November 04, 2026 Private & Confidential
Slide 3: Disclaimer
Disclaimer This presentation has been prepared by Krishna Institute of Medical Sciences Limited (the “Company”) solely for informational purposes. It should not be construed as an offer, solicitation, or recommendation to purchase or subscribe for any securities of the Company or its affiliates. The
Slide 4: Driven by a Vision
Driven by a Vision Affordable Quality Care VISION: Best-in-Class Facilities Patient Centric Systems & Processes S To be the most preferred NT healthcare services brand by TIE providing affordable care and best PA clinical outcomes to patients. Clinical Outcome Driven Excellence And to be the best pl
Slide 5: Multi Specialty Care
Multi Specialty Care Brain Eyes Bones and Spine Radiology • Neurology • Ophthalmology • Orthopedics • Imaging • Neurosurgery Gastro Intestinal Tract • Arthroscopic Surgery • Interventional Radiology • Psychiatry • Medical Gastroenterology • Spine Surgery Lab Services • Neuro Rehabilitation • Surgica
Slide 6: Dr. Bhaskara Rao Bollineni - Visionary Behind KIMS
Dr. Bhaskara Rao Bollineni - Visionary Behind KIMS Chairman & Managing Director A legend in CT Surgery, Dr. Bhaskara Rao Bollineni {MBBS, MS, DNB (CT Surgery)} is one of the very few Cardio-Thoracic Surgeons in the country, who performed over 30000 surgeries in his career spanning over more than 25
Slide 7: Dr. Abhinay Bollineni
Dr. Abhinay Bollineni Executive Director & CEO Dr. Abhinay Bollineni joined KIMS Hospitals in 2013 and spent the next couple of years in Hospital Operations before taking charge of Strategy & Marketing for the Group in 2015. He was appointed as the CEO in 2019. Dr. Abhinay Bollineni completed MBBS f
Slide 8: Board of Directors
Board of Directors Dr. Bhaskara Rao Bollineni Dr. Abhinay Bollineni Mrs. Anitha Dandamudi Mr. Saumen Chakraborty Chairman & Managing Director Executive Director & CEO Whole-time Director Independent Director, Chairman (Audit Committee) Mr. Adwik Bollineni Mr. Venkata Ramudu Jasthi Mrs. Y. Prameela R
Slide 9: Shareholding Pattern - As on 30 September, 2026
Shareholding Pattern - As on 30 September, 2026 th Retail & Others, Retail Pre IPO, 9.8% Top Institutional Share Holders 6.3% Share Holder Share Holding % Promoters, 32.5% SBI MF 4.9% Kotak MF 4.8% AXIS MF 4.8% FII, 17.6% HDFC MF 4.0% Invesco MF 3.6% Nomura 2.7% Vanguard 2.4% Amansa Holdings Private
Slide 10: Modern Medical Technology
Modern Medical Technology 4-Arm HD da Vinci MrGFUS Focussed Tulsa-Pro System Robotic Surgical Ultrasound A non- invasive procedure that System Revolutionary Knifeless Brain uses real-time MRI guidance Facilitates complex surgeries procedure for treating tremors. to precisely deliver thermal that are
Slide 11: Many Firsts...
Many Firsts... • First in Asia to do Trans catheter • India’s first COVID Double Lung • Number 1 in Nephrology treatments in Tricuspid Valve replacement transplant done in 2020 Andhra Pradesh procedure done in 2018 • India’s first Breathing Lung transplant • Number 1 in Neurosurgery & Poly • Largest
Slide 12: Key Accomplishments
Key Accomplishments NAL ACCRED TIO IT NA AT ER ION INT QU Y ET LI AF A TY & PAT I E N T S Pharmacie De Qualite (PDQ) American Accreditation Commission Certification Overall PDQ Evaluation ‘Patient Friendly Hospital’ NABH Digital Standards Accreditation Ranked No. 1 Hospital International (AACI) Perf
Slide 13: Consistent Performer over 2 decades
Consistent Performer over 2 decades (Rupees in Millions) 39,308 7,584 30,670 7,590 25,143 .1% 6,200 .9% R : 28 26 G CA GR: 22,235 CA 5,766 16,711 5,217 11,287 2,412 4,280 773 1,311 317 263 42 2005 2010 2015 2020 2022 2023 2024 2025 2026 2005 2010 2015 2020 2022** 2023 2024 2025 2026 No. of No. of No
Slide 14: KIMS Journey: From Regional Leader to National Healthcare
KIMS Journey: From Regional Leader to National Healthcare Roadmap Overall Bed Capacity of 10,000+ Beds Year Andhra Pradesh Telangana Maharashtra Keralam Karnataka Tamil Nadu 2000 Nellore - 250 2001 Rajahmundry - 195 2004 Secunderabad - 1000 2011 Srikakulam - 300 2014 Kondapur - 220 2017 Ongole - 350
Slide 15: KIMS Journey: Strategic Levers for Future Growth
KIMS Journey: Strategic Levers for Future Growth Consistent Growth over 2 decades Achieved 26%+ CAGR in Revenue and 28%+ CAGR in EBITDA, reflecting sustained operational excellence and strategic expansion. Delivering high-quality care through affordable healthcare models, advanced These transplant p
Slide 16: Q2 FY27 Updates
Q2 FY27 Updates 15 Private & Confidential
Slide 17: Financial & Operational Highlights - 1/2
Financial & Operational Highlights - 1/2 (Rupees in Millions) Financial Highlights Particulars Q2 FY27 Q1 FY27 Q2 FY26 QoQ (%) YoY (%) H1 FY27 H1 FY26 YoY (%) Operating Revenue 13,444 11,795 9,607 14.0% 39.9% 25,239 18,323 37.7% Other Income 186 164 42 13.4% 342.9% 350 113 209.7% Total Revenue 13,63
Slide 18: Financial & Operational Highlights - 2/2
Financial & Operational Highlights - 2/2 Operational Highlights Particulars Q2 FY27 Q1 FY27 Q2 FY26 QoQ (%) YoY (%) H1 FY27 H1 FY26 YoY (%) IP Volume 81,668 72,493 64,288 12.7% 27.0% 1,54,161 1,21,563 26.8% OP Volume 7,31,010 6,58,617 5,92,725 11.0% 23.3% 13,89,627 11,05,124 25.7% ARPOB (Rs) 48,277
Slide 19: Group Operating Performance
Group Operating Performance IP VOLUME (‘000) OP VOLUME (‘000) 26.8% 12.7% 25.7% 11.0% 154 82 1,390 731 72 659 122 64 1,105 593 H1 FY26 H1 FY27 Q2 FY26 Q1 FY27 Q2 FY27 H1 FY26 H1 FY27 Q2 FY26 Q1 FY27 Q2 FY27 OCCUPIED BEDS / OCCUPANCY %* ARPOB (‘000) 12.4% 2.3% 2,903 3,045 47.8 48.3 2,761 42.5 47.2 2,
Slide 20: Group Operating and Financial Performance
Group Operating and Financial Performance Particulars FY 26 H1 FY27 H1 FY26 Q2 FY26 Q1 FY27 Q2 FY27 Bed Capacity# 6,464 7,459 6,114 6,114 7,459 7,459 Operational Beds 4,717 5,605 4,560 4,560 5,504 5,605 Census Beds 3,845 4,508 3,747 3,747 4,413 4,508 Non Census Beds 872 1,097 813 813 1,091 1,097 Occ
Slide 21: Group Financial Performance
Group Financial Performance (Rupees in Millions) TOTAL REVENUE EBITDA 14.0% 16.3% 38.8% 27.2% 25,589 13,630 5,187 2,789 11,959 4,079 9,649 2,398 18,436 2,082 H1 FY26 H1 FY27 Q2 FY26 Q1 FY27 Q2 FY27 H1 FY26 H1 FY27 Q2 FY26 Q1 FY27 Q2 FY27 PBT* PAT* (22.5%) 88.3% (28.0%) 102.4% 2,105 1,066 1,570 757 9
Slide 22: Operational and Financial Performance - 1/3
Operational and Financial Performance - 1/3 Telangana Andhra Pradesh Particulars FY26 H1 FY26 H1 FY27 Q2 FY26 Q1 FY27 Q2 FY27 FY26 H1 FY26 H1 FY27 Q2 FY26 Q1 FY27 Q2 FY27 Bed Capacity# 1,882 1,882 2,669 1,882 2,669 2,669 2,314 2,314 2,314 2,314 2,314 2,314 Operational Beds 1,559 1,559 2,009 1,559 2,
Slide 23: Operational and Financial Performance - 2/3
Operational and Financial Performance - 2/3 Maharashtra Keralam Particulars FY26 H1 FY26 H1 FY27 Q2 FY26 Q1 FY27 Q2 FY27 FY26 H1 FY26 H1 FY27 Q2 FY26 Q1 FY27 Q2 FY27 Bed Capacity 959 959 959 959 959 959 509 509 717 509 717 717 Operational Beds 637 637 695 637 637 695 401 401 609 401 609 609 Census B
Slide 24: Operational and Financial Performance - 3/3
Operational and Financial Performance - 3/3 Karnataka Group Particulars FY26 H1 FY26 H1 FY27 Q2 FY26 Q1 FY27 Q2 FY27 FY26 H1 FY26 H1 FY27 Q2 FY26 Q1 FY27 Q2 FY27 Bed Capacity# 800 450 800 450 800 800 6,464 6,114 7,459 6,114 7,459 7,459 Operational Beds 280 150 340 150 340 340 4,717 4,560 5,605 4,560
Slide 25: Ramp-up of Keralam Units
Ramp-up of Keralam Units (Rupees in Millions) Kannur EBITDA Positive Kollam EBITDA Positive Palakkad EBITDA Positive 347.0 227.1 259.4 353.6 272.4 203.1 219.3 152.2 30.6 52.7 56.1 28.0 18.5 14.8 7.0 (21.1) Q2FY26 Q1FY27 Q2FY27 Q2FY26 Q1FY27 Q2FY27 Q1FY27 Q2FY27 NABH - In Pipeline NABH - In Pipeline
Slide 26: Ramp-up of Maharashtra Units
Ramp-up of Maharashtra Units (Rupees in Millions) Nashik EBITDA Positive Thane EBITDA Positive 268.4 645.4 248.8 176.4 482.0 298.1 21.9 10.8 29.7 (64.7) (150.0) (79.9) Q2FY26 Q1FY27 Q2FY27 Q2FY26 Q1FY27 Q2FY27 NABH - In Pipeline NABH - Accredited Revenue EBITDA • Successfully performed North Mah
Slide 27: Ramp-up of AP & Karnataka Units
Ramp-up of AP & Karnataka Units (Rupees in Millions) Vizag Seethammadhara EBITDA Positive Mahadevapura (Bengaluru) EBITDA Positive Electronic City (Bengaluru) 494.1 696.0 410.3 398.8 238.9 550.6 259.0 29.0 63.2 60.7 14.6 52.1 (182.8) (15.8) (176.6) (106.0) Q2FY26 Q1FY27 Q2FY27 Q2FY26 Q1FY27 Q2FY27 Q
Slide 28: Ramp-up of O&M Units
Ramp-up of O&M Units (Rupees in Millions) Sangli EBITDA Positive Guntur EBITDA Positive Kompally 284.8 351.4 121.4 226.4 277.4 317.9 247.6 230.8 24.7 26.6 22.6 14.2 18.7 (30.9) (92.1) (22.7) Q2FY26 Q1FY27 Q2FY27 Q2FY26 Q1FY27 Q2FY27 Q1FY27 Q2FY27 NABH - In Pipeline NABH - In Pipeline NABH - In Pipel
Slide 29: Revenue Mix & Cluster Profile (Group H1FY27)
Revenue Mix & Cluster Profile (Group H1FY27) SPECIALITY MIX PAYOR MIX CLUSTER TOTAL REVENUE Aarogyasri Keralam 6.3% Karnataka 7.5% 4% Others Cardiac Sciences 24% 14% Maharashtra Corporate Cash 12.9% 11% 53% Telangana 51.8% Renal Sciences 9% Mother & Child Andhra Pradesh 9% 21.5% Organ Oncology Trans
Slide 30: Key Achievements in Q2 FY27
Key Achievements in Q2 FY27 29 Private & Confidential
Slide 31: Key Achievements in Q2 FY27
Key Achievements in Q2 FY27 30 Private & Confidential
Slide 32: Corporate Structure (As on 30 September 2026)
Corporate Structure (As on 30 September 2026) th Krishna Institute of Medical Sciences Limited Units Wholly Owned Subsidiaries KIMS Secunderabad KIMS Nellore KIMS Rajahmundry KIMS Ongole KIMS Thane KIMS Seethammadhara KIMS Swastha KHPL (100%) (100%) (100%) (100%) (100%) Visakhapatnam Keralam Rajahmu
Slide 33: Thank You
Thank You 32 Private & Confidential
Krishna Institute of Medical Sciences — Q2 FY27 Earnings Presentation on 6ix